Chips, pills, and robotaxis: Tuesday delivers

🔔 After the Bell

🎯 Session Review

Tuesday turned out to be a pretty good day to own stocks. The S&P 500 climbed 0.89% to close at 7,509.20, the Nasdaq led the charge with a 1.29% gain, and the Dow added 385 points for good measure. All three major indices closed in the green, and the mood on the street matched the scoreboard.

The rally was not random. Real catalysts showed up today, from semiconductor stocks staging a comeback to a blockbuster HIV drug trial result, plus Apple dropping a product strategy news bomb. When the news flow is this rich, markets tend to respond.

Bitcoin also joined the party, climbing 1.82% to $66,414, while the Dollar Index ticked up slightly to 101.18. Treasury yields edged higher across the board, with the 10-year at 4.63%, but that was not enough to spook equities today.

A drilling crew just broke a record nobody expected [ad]

📊 Today's Market Movers

▲ Gainers AEHR ▲ +27.86% RGC ▲ +18.82% NBIS ▲ +18.78% CBRS ▲ +17.92% OUST ▲ +17.0%

▼ Losers BXBL ▼ -18.43% CHRN ▼ -12.15% DHR ▼ -10.92% MSCI ▼ -10.35% TENB ▼ -9.72%

🚀 Key Catalysts

Chip stocks were the headline grabbers. Micron (MU) led a broader semiconductor rebound after analysts argued the recent sell-off was overdone and pointed to open-source AI models as a fresh tailwind for memory demand. Nvidia (NVDA) also moved higher, with Wall Street analysts growing increasingly bullish ahead of earnings season. When the two biggest names in AI hardware are both trending up on the same day, the Nasdaq tends to notice.

Healthcare made a serious statement. Gilead Sciences (GILD) and Merck (MRK) announced their once-weekly HIV pill successfully suppressed the virus in two late-stage trials. That is not a minor update. It is potentially the first treatment of its kind, and the market rewarded the news accordingly.

Apple (AAPL) added another layer to today's rally after Bloomberg reported the company is launching a device leasing program called Apple Upgrade on July 28. It is a direct play to boost hardware sales volume, and investors liked what they heard. Tesla (TSLA) also grabbed attention by expanding its robotaxi service to Orlando and Tampa, signaling that the autonomous ride-hailing rollout is moving faster than skeptics expected.

When I found Rolls-Royce under $2, most people thought I was crazy [ad]

"By July 30, Elon Musk's Prophecy Will Fulfill Itself"

🎭 Investor Mood

Today's mood title fits: investors came in with conviction. This was not a timid, low-volume drift higher. Multiple sectors moved together, driven by actual news rather than speculation. That kind of broad participation tends to signal genuine confidence rather than momentum chasing.

Nebius Group (NBIS) was the standout on the trending list, surging over $34 to close at $216.92. That kind of move in an AI-adjacent name reflects just how hungry the market is for anything with a credible AI growth story attached to it. Meanwhile, 3M (MMM) jumped $11.65, suggesting investors are also willing to revisit beaten-down industrials when the macro backdrop feels cooperative.

Not everyone celebrated. Danaher (DHR) dropped nearly $22, and MSCI Inc. (MSCI) shed over $64. That is a useful reminder that even in strong market sessions, stock-specific risks do not take a day off. The divergence keeps things honest.

Firm That Predicted 2008, 2020, 2022: Right Now Looks Worse [ad]

🔍 5 Focus Points for Tomorrow

🤖	Watch Nvidia (NVDA) closely as earnings season approaches and analyst optimism continues to build around AI infrastructure spending

📋	Track Gilead (GILD) and Merck (MRK) for regulatory filing timelines following their landmark once-weekly HIV pill trial results

🏛️	Apple (AAPL) launches its Apple Upgrade leasing program on July 28, a potential inflection point for hardware revenue strategy

🏛️	Monitor 10-year Treasury yields at 4.63% for any further creep higher that could pressure growth stock valuations

📋	Tesla (TSLA) robotaxi expansion into Orlando and Tampa is a scaling signal worth tracking ahead of the company's next earnings update

Elon's $480 Trillion Currency Masterplan

💸 Bottom Line

So what do you take away from Tuesday? The AI trade is very much alive, and it is broadening. Chips, cloud infrastructure plays like Nebius, and even device-level hardware from Apple are all getting attention. When the thesis spreads across multiple layers of the tech stack, it tends to have more staying power.

The biotech angle is worth watching closely. A successful late-stage HIV trial from Gilead and Merck is not just a one-day headline. Regulatory filings will follow, and that process could keep both stocks in focus for months. Health care has been an underappreciated driver this earnings cycle, and today's news is a reminder to keep it on your radar.

Treasury yields crept higher but did not derail anything today. The 10-year at 4.63% and the 30-year at 5.13% are levels markets have learned to live with. If yields spike meaningfully from here, that calculus could change. For now, the bulls have the momentum and the news flow on their side.

Do You Have A Plan For July 28th? [ad]